Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SENP1-IN-1 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity.
Description | SENP1-IN-1 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity. |
In vitro | SENP1-IN-1 has been observed to enhance the sensitivity of tumor cells to irradiation, according to research findings. When administered at concentrations ranging from 0.7 to 20 μM for a duration of 72 hours, SENP1-IN-1 exhibits cytotoxic effects on Hela cells, with an IC50 value exceeding 20 μM. This data was established through a Cell Cytotoxicity Assay conducted on Hela cells using varying concentrations (0.7 μM, 2.2 μM, 6.6 μM, 20 μM) over the specified incubation period, further confirming its cytotoxic potency. |
Synonyms | SENP1-IN-1 |
Molecular Weight | 570.859 |
Formula | C35H58N2O4 |
CAS No. | 2416910-69-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SENP1-IN-1 2416910-69-3 SENP-1-IN-1 SENP1 IN 1 SENP1IN1 inhibitor inhibit